Gene Therapy for Blindness
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Sight-restoring therapy for the visually impaired and blind is a major unmet medical need. Ocular gene therapy is a rational choice for restoring vision or preventing the loss of vision because most blinding diseases originate in cellular components of the eye, a compartment that is optimally suited for the delivery of genes, and many of these diseases have a genetic origin or genetic component. In recent years we have witnessed major advances in the field of ocular gene therapy, and proof-of-concept studies are under way to evaluate the safety and efficacy of human gene therapies. Here we discuss the concepts and recent advances in gene therapy in the retina. Our review discusses traditional approaches such as gene replacement and neuroprotection and also new avenues such as optogenetic therapies. We conjecture that advances in gene therapy in the retina will pave the way for gene therapies in other parts of the brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phototransduction by retinal ganglion cells that set the circadian clock
Berson, D. M., Dunn, F. A., & Takao, M. (2002) · Science · doi:10.1126/science.1067262 · Cited by 3,629 · cited 1×
“The peak sensitivity of the melanopsin-mediated response in these ganglion cells is ∼490 nm (Berson et al. 2002); therefore, the more red shifted the sensor is, the less pupillary constriction it causes.”
BackgroundSafety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145 · cited 2×
“In humans, phase I clinical trials simultaneously conducted by three different groups demonstrated that AAV-mediated RPE65 gene therapy was safe and led to a slight improvement in vision, mostly under dark-adapted conditions (Bainbridge et al. 2008, Hauswirth et al. 2008, Maguire et al. 2008).”
BackgroundThe plastic human brain cortex
Pascual-Leone, A., Amedi, A., Fregni, F., & Merabet, L. B. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144216 · Cited by 1,929 · cited 1×
“Finally, studies have demonstrated that the visual cortex can be activated in congenitally blind patients by stimulating other sensory pathways, showing the plasticity of the cortex (Pascual-Leone et al. 2005, Reich et al. 2012).”
BackgroundEffect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Gene therapy restores vision in a canine model of childhood blindness
Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-92 · Cited by 1,202
Hauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954
Subretinal electronic chips allow blind patients to read letters and combine them to words
Zrenner, E., Bartz-Schmidt, K. U., Benav, H., Besch, D., Bruckmann, A., Gabel, V.-P., Gekeler, F., Greppmaier, U., Harscher, A., Kibbel, S., et al. (2011) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2010.1747 · Cited by 819 · cited 4×
“Mutant capsids sometimes allow better transduction efficiencies or different tropisms over the natural variants.”
BackgroundMethodInfluentialLeber congenital amaurosis: Genes, proteins and disease mechanisms
den Hollander, A. I., Roepman, R., Koenekoop, R. K., & Cremers, F. P. M. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.003 · Cited by 811
Eye Smarter than Scientists Believed: Neural Computations in Circuits of the Retina
Gollisch, T., & Meister, M. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.009 · Cited by 795 · cited 2×
“The retina can be viewed as a parallel image processor that acquires images via a mosaic of photoreceptors and that extracts various visual features from the acquired images (Azeredo da Silveira & Roska 2011, Gollisch & Meister 2010, Masland 2001, Wässle 2004) (Figure 1).”
BackgroundOptogenetic investigation of neural circuits underlying brain disease in animal models
Tye, K. M., & Deisseroth, K. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3171 · Cited by 745 · cited 1×
“F or p er so na l u se o nl y. large number of mutant channelrhodopsins have been produced, with different functional properties, and new light-gated pumps have been isolated from different species (Chow et al. 2012; Kleinlogel et al. 2011a,b; Prigge et al. 2012; Tye & Deisseroth 2012).”
Background
Cited by
Microbial and Animal Rhodopsins: Structures, Functions, and Molecular Mechanisms
Ernst, O. P., Lodowski, D. T., Elstner, M., Hegemann, P., Brown, L. S., & Kandori, H. (2014) · Chemical Reviews · doi:10.1021/cr4003769 · Cited by 1,153
Partial recovery of visual function in a blind patient after optogenetic therapy
Sahel, J.-A., Boulanger-Scemama, E., Pagot, C., Arleo, A., Galluppi, F., Martel, J. N., Esposti, S. D., Delaux, A., de Saint Aubert, J.-B., de Montleau, C., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01351-4 · Cited by 700
Self-citationDias, M. F., Joo, K., Kemp, J. A., Fialho, S. L., da Silva Cunha, A., Woo, S. J., & Kwon, Y. J. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.004 · Cited by 413
Retinal remodeling in human retinitis pigmentosa
Jones, B. W., Pfeiffer, R. L., Ferrell, W. D., Watt, C. B., Marmor, M., & Marc, R. E. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.03.018 · Cited by 335
Emerging therapies for inherited retinal degeneration
Scholl, H. P. N., Strauss, R. W., Singh, M. S., Dalkara, D., Roska, B., Picaud, S., & Sahel, J.-A. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2838 · Cited by 219
Self-citation
Metadata
- Authors
- Sahel, J.-A., & Roska, B.
- Venue
- Annual Review of Neuroscience
- Publisher
- Annual Reviews
- Published
- 2013-07-08
- Volume
- 36
- Issue
- 1
- Pages
- 467-488
- ISSN
- 0147-006X (ISSN-L)
- 1545-4126
- OpenAlex
- W2157973328
- Cited by
- 140
- References
- 23
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gene Therapy for Blindness. https://app.cochat.ai/papers/10.1146/annurev-neuro-062012-170304
- The paper
- Sahel, J.-A., & Roska, B. (2013). Gene Therapy for Blindness. Annual Review of Neuroscience. https://doi.org/10.1146/annurev-neuro-062012-170304
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.